The activation of OR13C4, an olfactory receptor, involves intricate molecular interplay where specific chemical compounds can enhance its functional activity through various cellular mechanisms. For instance, direct stimulation of adenylyl cyclase by certain compounds results in an increase in cyclic AMP (cAMP) levels, leading to the phosphorylation of proteins that interact with OR13C4, thereby enhancing its signal transduction. Moreover, the employment of β-adrenergic agonists that elevate intracellular cAMP further amplifies OR13C4's response through the activation of protein kinase A (PKA). The inhibition of phosphodiesterase activity similarly sustains the activation of OR13C4 via prolonged cAMP and PKA signaling, while prostaglandins activating G-protein-coupled receptors can lead to an increase in cAMP, potentially fortifying OR13C4 signaling through enhanced G-protein activity.
In addition to these pathways, other compounds indirectly facilitate OR13C4 function through diverse biochemical mechanisms. Histone deacetylase inhibitors, for instance, can increase chromatin accessibility, indirectly fostering OR13C4 function by making transcriptional machinery more available. Certain ionophores can modulate intracellular metal ion concentrations, subtly influencing G-protein-coupled receptor signaling. Moreover, compounds known to activate transient receptor potential channels or antagonize adenosine receptors may alter intracellular calcium levels or cAMP concentrations, respectively, which could indirectly enhance OR13C4 signaling. Similarly, the selective inhibition of specific phosphodiesterases, stimulation of nicotinic acetylcholine receptors, and modulation of cellular kinases and transcriptional regulation by other chemicals can lead to an upregulation of OR13C4 activity. Activation of sirtuins by particular compounds also plays a role, potentially influencing OR13C4 activity through deacetylation of transcription factors, contributing to the complex regulatory network that governs the activation of this olfactory receptor.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels which may enhance OR13C4 signaling by phosphorylation of proteins that interact with the olfactory receptor. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
β-adrenergic agonist that elevates intracellular cAMP, potentially enhancing OR13C4 response via cAMP-dependent protein kinase A (PKA) activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-selective phosphodiesterase inhibitor, preventing cAMP degradation, which may sustain activation of OR13C4 through prolonged PKA signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Prostaglandin that activates G-protein-coupled receptors leading to cAMP increase, potentially amplifying OR13C4 signaling through enhanced G-protein activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Histone deacetylase inhibitor that could increase chromatin accessibility, indirectly facilitating OR13C4 function by enhancing availability of transcription factors. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Zinc ionophore that can increase intracellular zinc concentration, which may influence OR13C4 function via modulation of G-protein-coupled receptor signaling. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $94.00 $173.00 $255.00 $423.00 | 26 | |
Activator of TRPV1 channels, potentially increasing intracellular calcium levels that might indirectly enhance OR13C4 signaling via calcium-calmodulin kinase pathways. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Antagonist of adenosine receptors leading to increased cAMP, which can indirectly support OR13C4 activity through elevated PKA signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Selective phosphodiesterase-4 inhibitor, increasing cAMP levels and potentially facilitating OR13C4 signaling through enhanced PKA activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Modulator of multiple signaling pathways, can indirectly upregulate OR13C4 activity through alterations in cellular kinase activity and transcriptional regulation. | ||||||